KRMAYURVED Share Price | KRM Ayurveda Ltd Stock Analysis & Recommendation

Q: Why is KRM Ayurveda Ltd falling/rising?

As of 10-Aug, KRM Ayurveda Ltd's stock price is rising, currently at 329.80, reflecting a change of 27.8 or 9.21% increase. This upward movement can be attributed to several factors. Over the past week, the stock has outperformed the benchmark Sensex, showing a gain of 14.28% compared to the Sensex's decline of 0.77%. Additionally, the stock has demonstrated strong performance over the past month, with a rise of 27.34%, while the Sensex has only increased by 1.56%.The stock is also trading above its moving averages across various time frames, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages, indicating a strong bullish trend. Furthermore, today's performance shows that KRM Ayurveda has outperformed its sector by 9.38%. However, it is worth noting that there has been a decline in investor participation, with delivery volume falling by 18.21% against the 5-day average, which could suggest a potential concern for future trading activity. Despite this, the overall positive performance metrics indicate that the stock is currently on an upward trajectory.

Q: What does KRM Ayurveda do?

Overview:KRM Ayurveda Ltd operates a network of hospitals and clinics in India and offers telemedicine consulting and sales, positioning itself within the healthcare services industry as a micro-cap company.History:KRM Ayurveda Limited was incorporated as a Private Limited Company on September 03, 2019, and later converted into a Public Limited Company on December 24, 2024. Revenue and profit data for the latest quarter are not available.Financial Snapshot:Most recent Net Sales: N/AMost recent Net Profit: N/AMarket-cap value: INR 493 Cr (Micro Cap)Key Metrics:P/E: 24.00Industry P/E: 60Dividend Yield: 0.00%Debt-Equity: -0.41Return on Equity: 17.54%Price-to-Book: 4.30Contact Details:Registrar Address: Not available.

Q: How big is KRM Ayurveda?

As of 10th June, Market Cap: KRM Ayurveda Ltd has a market capitalization of 493.00 Cr, categorizing it as a Micro Cap company.Recent Quarterly Performance: There is no valid financial data available for Net Sales and Net Profit for the latest four quarters.Balance Sheet Snapshot: The reporting period is March 2025, with Shareholder's Funds amounting to 23.88 Cr and Total Assets valued at 66.79 Cr.

Q: Who are the peers of the KRM Ayurveda?

Peers: The peers of KRM Ayurveda are Tarsons Products, 3B Blackbio, Health X Platfor, Take Solutions, Nureca, QMS Medical, Hemant Surgical, Prevest Denpro, and One Global Serv.Quality Snapshot: Excellent management risk is observed at Prevest Denpro, while Average management risk is found at 3B Blackbio, QMS Medical, and Hemant Surgical, and the rest have Below Average management risk. Growth is Excellent at One Global Serv, Good at Hemant Surgical, and Average at Health X Platfor, while the rest exhibit Below Average growth. Capital Structure is Excellent at 3B Blackbio and Prevest Denpro, Good at Tarsons Products and Nureca, Average at QMS Medical, and the rest have Below Average capital structure.Return Snapshot: The peer with the highest 1-year return is Take Solutions at 228.18%, while the lowest is Tarsons Products at -44.95%. KRM Ayurveda's 1-year return is not available for comparison. Additionally, Nureca, Take Solutions, and Health X Platfor have negative six-month returns.

Price Point

High/Low

1Day

52 Week

Valuation

Technical

Day's Volume

CASH

2.4 lacs (195.57%) Volume

Shareholding (Mar 2026)

FII

3.86%

Held by 5 FIIs

DII

3.34%

Held by 0 DIIs

Promoter

69.15%

Why is KRM Ayurveda Ltd falling/rising?

11-Aug-2026

As of 10-Aug, KRM Ayurveda Ltd's stock price is at 329.80, reflecting a 9.21% increase. The stock has outperformed the Sensex and is trading above its moving averages, indicating a strong bullish trend, although a decline in investor participation may raise concerns for future trading.

View full answer

Which are the latest news on KRM Ayurveda?

10-Aug-2026

No latest news for KRM Ayurveda found.

What does KRM Ayurveda do?

11-Jun-2026

KRM Ayurveda Ltd operates hospitals and clinics in India, offering telemedicine services. It is a micro-cap company with a market cap of INR 493 Cr, and it was converted to a Public Limited Company in December 2024.

View full answer

How big is KRM Ayurveda?

11-Jun-2026

As of 10th June, KRM Ayurveda Ltd has a market capitalization of 493.00 Cr, classifying it as a Micro Cap company. There is no valid financial data available for Net Sales and Net Profit for the latest four quarters.

View full answer

Who are the peers of the KRM Ayurveda?

11-Jun-2026

KRM Ayurveda's peers include Tarsons Products, 3B Blackbio, Health X Platfor, Take Solutions, Nureca, QMS Medical, Hemant Surgical, Prevest Denpro, and One Global Serv. Their management risks and growth rates vary, with Take Solutions showing the highest 1-year return at 228.18% and Tarsons Products the lowest at -44.95%.

View full answer

Compare KRM Ayurveda with Similar Stocks

Gaudium IVF Hemant Surgical Health X Platfor

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Dashboard

Unrated Stock - No Analysis Available

Mojo Parameters

Loading Valuation Snapshot...

Stock DNA

Industry

Healthcare Services

Market cap

INR 691 Cr (Micro Cap)

P/E

34.00

Industry P/E

Dividend Yield

0.00%

Debt Equity

-0.41

Return on Equity

17.54%

Price to Book

5.60

Revenue and Profits:

Net Sales:

32 Cr

(Quarterly Results - Jun 2026)

Net Profit:

9 Cr

Total Returns

Total Returns (Price + Dividend)

Dividend Yield (0%)

TimePeriod

Price Return

Dividend Return

Total Return

3 Months

26.34%

6 Months

69.35%

1 Year

0.0%

2 Years

0.0%

3 Years

0.0%

4 Years

0.0%

5 Years

0.0%

KRM Ayurveda for the last several years.

Risk Adjusted Returns v/s

Returns Beta

Beta has not been calculated since enough price history is not available

News & Corporate Actions

News

No Recent News for the Company

Announcements

No announcement available

Corporate Actions

BOARD MEETING

No Upcoming Board Meetings

DIVIDEND

No Dividend history available

SPLITS

No Splits history available

BONUS

No Bonus history available

RIGHTS

No Rights history available

Key Factors

Quality key factors

Factor

Value

Sales Growth (5y)

EBIT Growth (5y)

EBIT to Interest (avg)

6.09

Debt to EBITDA (avg)

1.66

Net Debt to Equity (avg)

Sales to Capital Employed (avg)

1.14

Tax Ratio

24.73%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

7.20%

ROCE (avg)

41.70%

ROE (avg)

Valuation key factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

5.99

EV to EBIT

21.78

EV to EBITDA

20.97

EV to Capital Employed

9.51

EV to Sales

6.29

PEG Ratio

Dividend Yield

ROCE (Latest)

43.66%

ROE (Latest)

17.54%

Technicals key factors

Indicator

Weekly

Monthly

MACD

RSI

No Signal

Bollinger Bands

Bullish

KST

Dow Theory

No Trend

Bullish

OBV

No Trend

Bullish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Shareholding

Shareholding Snapshot : Mar 2026

Shareholding Compare (%holding)

Majority shareholders

Promoters

Pledged Promoter Holdings

None

Mutual Funds

Held by 0 Schemes

FIIs

Held by 5 FIIs (3.86%)

Promoter with highest holding

Puneet Dhawan (90.79%)

Highest Public shareholder

Shyam Sunder (0.81%)

Individual Investors Holdings

14.87%

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Standalone) - Jun'26 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Jun 2026 is 0.34% vs 30.56% in Mar 2026",
        "dir": -1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "QoQ Growth in quarter ended Jun 2026 is 16.26% vs 92.84% in Mar 2026",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Jun'26",
        "Mar'26",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "32.32",
          "val2": "32.21",
          "chgp": "0.34%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "12.01",
          "val2": "10.99",
          "chgp": "9.28%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.06",
          "val2": "0.63",
          "chgp": "-90.48%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "9.08",
          "val2": "7.81",
          "chgp": "16.26%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "37.16%",
          "val2": "34.12%",
          "chgp": "3.04%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "header": "Half Yearly Results Snapshot (Standalone) - Mar'26",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": " Growth in half year ended Mar 2026 is 10.28% vs 18.41% in Sep 2025",
        "dir": -1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": " Growth in half year ended Mar 2026 is 46.19% vs 70.29% in Sep 2025",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Mar'26",
        "Sep'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "53.33",
          "val2": "48.36",
          "chgp": "10.28%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "17.54",
          "val2": "12.84",
          "chgp": "36.60%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "1.54",
          "val2": "1.59",
          "chgp": "-3.14%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "11.90",
          "val2": "8.14",
          "chgp": "46.19%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "32.89%",
          "val2": "26.55%",
          "chgp": "6.34%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "header": "Nine Monthly Results Snapshot (Standalone) - Jun'26",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      }
    ],
    "table": {
      "header": [
        "Jun'26",
        "",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "80.68",
          "val2": "NA",
          "chgp": "NA",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "24.85",
          "val2": "NA",
          "chgp": "NA",
          "chgp_class": "neutral"
        },
        {
          "field": "Interest",
          "val1": "1.65",
          "val2": "NA",
          "chgp": "NA",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "NA",
          "chgp": "NA",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "17.22",
          "val2": "NA",
          "chgp": "NA",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "30.80%",
          "val2": "NA%",
          "chgp": "NA",
          "chgp_class": "neutral"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Standalone) - Mar'26",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2026 is 32.84% vs 13.98% in Mar 2025",
        "dir": 1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2026 is 79.48% vs 228.74% in Mar 2025",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Mar'26",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "101.69",
          "val2": "76.55",
          "chgp": "32.84%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "30.49",
          "val2": "18.74",
          "chgp": "62.70%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "3.25",
          "val2": "2.90",
          "chgp": "12.07%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "20.12",
          "val2": "11.21",
          "chgp": "79.48%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "29.98%",
          "val2": "24.48%",
          "chgp": "5.50%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Standalone) - Jun'26 - QoQ

Jun'26

Mar'26

Change(%)

Net Sales

32.32

32.21

0.34%

Operating Profit (PBDIT) excl Other Income

12.01

10.99

9.28%

Interest

0.06

0.63

-90.48%

Exceptional Items

0.00

Standalone Net Profit

9.08

7.81

16.26%

Operating Profit Margin (Excl OI)

37.16%

34.12%

3.04%

Values in Rs Cr.

Compare with Peers

Net Sales

QoQ Growth in quarter ended Jun 2026 is 0.34% vs 30.56% in Mar 2026

Standalone Net Profit

QoQ Growth in quarter ended Jun 2026 is 16.26% vs 92.84% in Mar 2026

All Quarterly Results

Half Yearly Results Snapshot (Standalone) - Mar'26

Mar'26

Sep'25

Change(%)

Net Sales

53.33

48.36

10.28%

Operating Profit (PBDIT) excl Other Income

17.54

12.84

36.60%

Interest

1.54

1.59

-3.14%

Exceptional Items

0.00

Standalone Net Profit

11.90

8.14

46.19%

Operating Profit Margin (Excl OI)

32.89%

26.55%

6.34%

Values in Rs Cr.

Compare with Peers

Net Sales

Growth in half year ended Mar 2026 is 10.28% vs 18.41% in Sep 2025

Standalone Net Profit

Growth in half year ended Mar 2026 is 46.19% vs 70.29% in Sep 2025

All Half Yearly Results

Nine Monthly Results Snapshot (Standalone) - Jun'26

Jun'26

Change(%)

Net Sales

80.68

Operating Profit (PBDIT) excl Other Income

24.85

Interest

1.65

Exceptional Items

0.00

Standalone Net Profit

17.22

Operating Profit Margin (Excl OI)

30.80%

NA%

Values in Rs Cr.

Compare with Peers

Net Sales

Not Applicable: The company has declared_date for only one period

Standalone Net Profit

Not Applicable: The company has declared_date for only one period

All Nine Monthly Results

Annual Results Snapshot (Standalone) - Mar'26

Mar'26

Mar'25

Change(%)

Net Sales

101.69

76.55

32.84%

Operating Profit (PBDIT) excl Other Income

30.49

18.74

62.70%

Interest

3.25

2.90

12.07%

Exceptional Items

0.00

Standalone Net Profit

20.12

11.21

79.48%

Operating Profit Margin (Excl OI)

29.98%

24.48%

5.50%

Values in Rs Cr.

Compare with Peers

Net Sales

YoY Growth in year ended Mar 2026 is 32.84% vs 13.98% in Mar 2025

Standalone Net Profit

YoY Growth in year ended Mar 2026 is 79.48% vs 228.74% in Mar 2025

All Annual Results

Company CV

About KRM Ayurveda Ltd

KRM Ayurveda Ltd

Micro Cap

Healthcare Services

KRM Ayurveda Limited was incorporated as a Private Limited Company as "KRM Ayurveda Private Limited" on September 03, 2019. Company was converted into a Public Limited Company and the name of Company was changed to "KRM Ayurveda Limited" on December 24, 2024. Company is operating a network of hospitals and clinics across multiple cities in India as well as marked its presence in abroad through tele medicines consulting and sales.

Company Coordinates

No Company Details Available